Long-term Follow-up Reveals High Posttreatment Mortality Rate Among Patients With Extensively Drug-Resistant Tuberculosis in the Country of Georgia
Author:
Affiliation:
1. Emory University School of Medicine, Atlanta, Georgia
2. National Center for Tuberculosis and Lung Diseases, Tbilisi, Georgia
3. Division of Infectious Diseases, Department of Medicine, Emory University School of Medicine, Atlanta, Georgia
Funder
National Institutes of Health
National Institute of Allergy and Infectious Diseases
National Center for Advancing Translational Sciences
Atlanta Clinical and Translational Science Institute
Georgia Clinical and Translational Science Alliance
REDCap
Emory University School of Medicine Dean’s Office
Publisher
Oxford University Press (OUP)
Subject
Infectious Diseases,Oncology
Link
http://academic.oup.com/ofid/article-pdf/6/4/ofz152/28529721/ofz152.pdf
Reference30 articles.
1. Treatment outcomes and long-term survival in patients with extensively drug-resistant tuberculosis;Kim;Am J Respir Crit Care Med,2008
2. Multi- and extensively drug-resistant tuberculosis in Latvia: trends, characteristics and treatment outcomes;Kuksa;Public Health Action.,2014
Cited by 9 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Global treatment outcomes of extensively drug-resistant tuberculosis in adults: A systematic review and meta-analysis;Journal of Infection;2023-09
2. Retreatment after loss to follow-up reduces mortality in patients with multidrug/rifampicin-resistant tuberculosis;ERJ Open Research;2023-06-15
3. Linezolid Exposure Is Associated with Cytopenias in Patients Treated for Multidrug-Resistant Tuberculosis;Antimicrobial Agents and Chemotherapy;2022-09-20
4. Low BMI increases all-cause mortality rates in patients with drug-resistant TB;The International Journal of Tuberculosis and Lung Disease;2022-04-01
5. Prognostic accuracy of time to sputum culture conversion in predicting cure in extensively drug-resistant tuberculosis patients: a multicentre retrospective observational study;BMC Infectious Diseases;2022-03-02
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3